Investigator Initiated Study – Schizophrenia
Investigator-Initiated Studies (IIS)
In general, IIS are not registrational studies, and they may be proof of concept or exploratory in nature. The budget for these studies should reflect fair market value for all costs and cannot include direct salary support for the principal investigator.
Boehringer Ingelheim may provide financial support and/or drugs for an approved IIS. BI does not serve as the regulatory sponsor for IIS. Investigators are required to apply for support via an online application process.
Although the research interests listed within the following therapeutic areas are of focus to BI, other research interests may be considered.
Schizophrenia
-
Evaluate patient assessment, symptom evaluation, and diagnosis patterns for negative symptoms
-
Evaluate patient assessment, symptom evaluation, and diagnosis patterns for cognitive symptoms
-
Assess the treatment landscape and trajectory of disease progression for cognitive and negative symptoms
PIRA™ proposals are AI generated and are not reviewed or endorsed by the sponsoring company.